Oncopeptides AB (publ) (STO:ONCO)
1.682
+0.037 (2.25%)
Jul 3, 2026, 5:29 PM CET
Oncopeptides AB Employees
Oncopeptides AB had 77 employees as of March 31, 2026. The number of employees increased by 2 or 2.67% since the number was last reported on December 31, 2025.
Employees
77
Change
2
Growth
2.67%
Revenue / Employee
1.08M SEK
Profits / Employee
-2.87M SEK
Market Cap
664.87M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 77 | 2 | 2.67% |
| Dec 31, 2025 | 75 | -5 | -6.25% |
| Dec 31, 2024 | 80 | 23 | 40.35% |
| Dec 31, 2023 | 57 | 16 | 39.02% |
| Dec 31, 2022 | 41 | -121 | -74.69% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sprint Bioscience AB | 30 |
| Xspray Pharma AB | 24 |
| Cantargia AB | 22 |
| Intervacc AB | 16 |
| Corline Biomedical AB | 13 |
| AlzeCure Pharma AB | 10 |
| Ascelia Pharma AB | 10 |
| SynAct Pharma AB | 8 |
Oncopeptides AB News
- 25 days ago - Oncopeptides AB Slides: FY 2026 - Filings
- 7 weeks ago - Oncopeptides AB Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Oncopeptides AB Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Oncopeptides AB Slides: Q1 2026 - Filings
- 7 weeks ago - Oncopeptides AB Transcript: Investor update - Transcripts
- 7 weeks ago - Oncopeptides AB Press release: Investor update - Filings
- 7 weeks ago - Oncopeptides AB Slides: Investor update - Filings
- 3 months ago - Oncopeptides AB Slides: FY 2026 - Filings